ReviewCell death discovery2026
Absolute dynamic and relative static: the relationship of glycolysis and OXPHOS in cancer development.
Review in Cell death discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- From metabolic intermediary to neurotransmitter: purinergic signaling in neurophysiology and vulnerability of brain circuits.Bioscience reports · 2026Review
- Redox Regulation in Glioblastoma: Mechanisms, Biomarkers, and Therapeutic Implications.International journal of molecular sciences · 2026Review
- Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects.Molecules (Basel, Switzerland) · 2026Review
- Harnessing Cuproptosis for Antitumor Immunity: A Review of Current Evidence and Therapeutic Strategies.Molecular carcinogenesis · 2026Review
- Experimental models for intestinal host-microbe interactions.EMBO molecular medicine · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For a significant period following the postulation of the Warburg effect, mitochondrial dysfunction and aerobic glycolysis were commonly accepted as the defining features of cancer. Currently, a deeper understanding of tumor metabolism has demonstrated that the energy phenotype of tumor cells is not solely glycolytic. Most cancer cells possess active mitochondria and still maintain the ability to undergo oxidative phosphorylation (OXPHOS) and utilize the tricarboxylic acid (TCA) cycle to support tumor growth. In this review, we examine the choice of energy supply pathways in tumor cells in both static and dynamic contexts. From a static standpoint, tumors contain cells that rely on glycolysis or OXPHOS for energy supply and demonstrate metabolic heterogeneity. Additionally, the simultaneous operation of glycolysis and OXPHOS establishes metabolic symbiosis. In contrast, cancer cells can also exhibit metabolic plasticity by dynamically shifting between glycolysis and OXPHOS to support tumor growth. This process is influenced by a variety of factors, such as the ever-changing tumor microenvironment, specific biological activities of tumor cells, and the effects of drug therapies. The relationship between glycolysis and OXPHOS suggests that in the process of cancer development, the stable state of energy metabolism is temporary, while the dynamic changes in energy metabolism are eternal, which is in line with the category of dialectical materialism and provides us with a new perspective for treating cancer.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.